...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Will we see a Zenith deal before years end???

It's an easy prediction that any such time estimates will most likely be waaaaay short of reality.  It's called the planning fallacy.

Share
New Message
Please login to post a reply